Who Owns Neuronetics Stock?
NASDAQ: STIMHealthcareMedical DevicesUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Ownership breakdown
- Held by institutions
- 53.96%
- Held by insiders
- 30.88%
- Institutional holders
- 103
- Institutions 54.0%
- Insiders 30.9%
- Public and other 15.2%
Who owns Neuronetics stock?
Institutional investors own about 54.0% of Neuronetics's shares, spread across 103 institutions that file 13F reports. That level of institutional ownership is moderate. Insiders, including executives, directors and large founding shareholders, hold 30.88% of STIM.
The largest institutional holders are Madryn Asset Management, LP (24.33%), UBS Group AG (2.99%) and Wexford Capital LP (2.63%). Together, the top 10 institutions control 40.3% of shares outstanding. In their latest filings, 4 of the top 10 institutions increased their STIM positions and 4 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of STIM
| Institution | Shares | % Held | Change |
|---|---|---|---|
| Madryn Asset Management, LP | 18.54M | 24.33% | +0.3% |
| UBS Group AG | 2.28M | 2.99% | -20.6% |
| Wexford Capital LP | 2.00M | 2.63% | +185.7% |
| FourWorld Capital Management, LLC | 1.74M | 2.29% | +17.1% |
| Lane Generational LLC | 1.63M | 2.14% | -8.0% |
| Vanguard Capital Management LLC | 1.51M | 1.98% | -26.4% |
| Masters Capital Management, LLC | 1.00M | 1.31% | 0.0% |
| AdvisorShares Investments, LLC | 742.79K | 0.97% | +20.4% |
| Ikarian Capital, LLC | 701.18K | 0.92% | 0.0% |
| Blackrock Inc. | 596.62K | 0.78% | -74.3% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of STIM
| Fund | Shares | % Held |
|---|---|---|
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 1.06M | 1.39% |
| AdvisorShares Trust-AdvisorShares Psychedelics ETF | 924.38K | 1.21% |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 424.32K | 0.56% |
| Fidelity Concord Street Trust-Fidelity Extended Market Index Fund | 199.80K | 0.26% |
| VANGUARD SCOTTSDALE FUNDS-Vanguard Russell 2000 Index Fund | 189.77K | 0.25% |
| iShares Trust-iShares Micro-Cap ETF | 92.88K | 0.12% |
| GOLDMAN SACHS TRUST-Goldman Sachs Absolute Return Tracker Fund | 87.05K | 0.11% |
| EQ Advisors Trust-1290 VT GAMCO Small Company Value Portfolio | 75.00K | 0.10% |
| Invesco Exch-Trd Fd. TRT II-Invesco NASDAQ Future Gen 200 ETF | 72.53K | 0.10% |
| Fidelity Concord Street Trust-Fidelity Total Market Index Fund | 69.40K | 0.09% |
Frequently asked questions
Who is the largest shareholder of Neuronetics?
Madryn Asset Management, LP is the largest institutional shareholder of STIM, owning 24.33% of shares outstanding (18.54M shares) as of its latest 13F filing.
What percentage of Neuronetics is owned by institutions?
Institutions own about 54.0% of STIM shares and 78.1% of the public float.
How much of Neuronetics do insiders own?
Insiders, such as officers and directors, own about 30.88% of STIM shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.